Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair.

Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Abstract Text:

J M Wozney,V Rosen,

The bone morphogenetic proteins are secreted signalling molecules that belong to the transforming growth factor beta family of growth and differentiation factors. Individual bone morphogenetic proteins are prominent at many sites during embryogenesis and are likely to be key regulators of early development and organogenesis. In vertebrates, one of the functions of bone morphogenetic like proteins is to induce formation of bone, cartilage, and connective tissues associated with the skeleton. This osteoinductive ability has led to the use of bone morphogenetic proteins as therapeutic agents for creation of new bone useful in treatment of skeletal injuries and diseases, and in oral and maxillofacial applications.

Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Publishing Authors By Initials

JM Wozney,V Rosen,

For similar peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta research abstracts see: peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta research

PUBMED ID PMID:

MEDLINE DATE:

Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Journal Published:

PUBLICATION TYPE: Review

Journal: Clinical orthopaedics and related research

VOLUME:

Page Numbers: 26-37

Journal Abbreviation: Clin. Orthop. Relat. Res.

ISSN: 0009-921X

DAY: 19

MONTH: Jan

YEAR: 1998

Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Information

Number of References: 76

LANGUAGE: eng

NlmUniqueID: 75674

Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Keywords Mesh Terms:

KEYWORDS: Transforming Growth Factor beta

MESH TERMS: physiology

Chemical & Substance for Abstract: Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Information

Substance Name: Bone Morphogenetic Protein Receptors

Registry Number: EC 2.7.1.37

Grant and Affiliation Information for Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair.

AFFILIATION: Genetics Institute, Inc., Cambridge, MA 02140, USA.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Orthop Relat Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair Related Publications

• A 29-year-old man with subcutaneous emphysema of the neck following blunt trauma.
• A web portal that enables collaborative use of advanced medical image processing and informatics tools through the Biomedical Informatics Research Network (BIRN).
• Acute rejection in HCV-infected liver transplant recipients: The great conundrum.
• Are stem cells drugs? The regulation of stem cell research and development.
• ArsD residues Cys12, Cys13, and Cys18 form an As(III)-binding site required for arsenic metallochaperone activity.
• BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing.
• Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair.
• Critical role for Ebf1 and Ebf2 in the adipogenic transcriptional cascade.
• Diagnosis and management of laryngopharyngeal reflux disease.
• Distinct roles of fibroblast growth factor receptor 1 and 2 in regulating cell survival and epithelial-mesenchymal transition.
• Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family.
• Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues.
• Fibroblast growth factor-10 prevents H2O2-induced cell cycle arrest by regulation of G1 cyclins and cyclin dependent kinases.
• Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8.
• Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis.
• I(Kr) contributes to the altered ventricular repolarization that determines long-term cardiac memory.
• Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum.
• Induction, characterization, and functional coupling of the high affinity chemokine receptor for RANTES and macrophage inflammatory protein-1 alpha upon differentiation of an eosinophilic HL-60 cell line.
• Integration is as essential as balance.
• Integration of prolactin and glucocorticoid signaling at the beta-casein promoter and enhancer by ordered recruitment of specific transcription factors and chromatin modifiers.
• Linking cost sharing to value: an unrivaled yet unrealized public health opportunity.
• Long-term cardiac memory in canine heart is associated with the evolution of a transmural repolarization gradient.
• Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence.
• Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics.
• Measuring the activities of the Sulfs: two novel heparin/heparan sulfate endosulfatases.
• Mouse and human granzyme B have distinct tetrapeptide specificities and abilities to recruit the bid pathway.
• Pre-clinical testing of a phased array ultrasound system for MRI-guided noninvasive surgery of the brain--a primate study.
• Stop! In the name of transforming growth factor-beta: keeping estrogen receptor-alpha-positive mammary epithelial cells from proliferating.
• Sulfated L-selectin ligands as a therapeutic target in chronic inflammation.
• The effects of aging on the bone inductive activity of recombinant human bone morphogenetic protein-2.